Oxygenta Pharmaceutical Ltd vs Zenlabs Ethica Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Oxygenta Pharmaceutical Ltd is ₹ 54.34 as of 30 Apr 15:30 . The P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Zenlabs Ethica Ltd changed from 17.9 on March 2021 to 76.1 on March 2025 . This represents a CAGR of 33.57% over 5 years The Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 34.15 crore on March 2022 to ₹ 294.24 crore on March 2025 . This represents a CAGR of 71.33% over 4 yearsThe Market Cap of Zenlabs Ethica Ltd changed from ₹ 13.77 crore on March 2021 to ₹ 20.32 crore on March 2025 . This represents a CAGR of 8.09% over 5 years The revenue of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ 33.93 crore as compare to the Sep '25 revenue of ₹ 14.25 crore. This represent the growth of 138.11% The revenue of Zenlabs Ethica Ltd for the Dec '25 is ₹ 12.43 crore as compare to the Sep '25 revenue of ₹ 12.49 crore. This represent the decline of -0.48% The ebitda of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ -4.08 crore as compare to the Sep '25 ebitda of ₹ -4.63 crore. This represent the decline of -11.88% The ebitda of Zenlabs Ethica Ltd for the Dec '25 is ₹ -1.56 crore as compare to the Sep '25 ebitda of ₹ 0.51 crore. This represent the decline of -405% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ -1.36 crore to ₹ -4.84 crore over 7 quarters. This represents a CAGR of 106.55% The net profit of Zenlabs Ethica Ltd changed from ₹ 0.04 crore to ₹ -2.01 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zenlabs Ethica Ltd changed from 33.21 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 years .

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990.
The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited.
Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.

About Zenlabs Ethica Ltd

Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993.
The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network.
It deals into marketing and distribution of pharmaceutical products and has grown to be of India's top pharmaceutical companies in 2019. The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people.
Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.

FAQs for the comparison of Oxygenta Pharmaceutical Ltd and Zenlabs Ethica Ltd

Which company has a larger market capitalization, Oxygenta Pharmaceutical Ltd or Zenlabs Ethica Ltd?

Market cap of Oxygenta Pharmaceutical Ltd is 200 Cr while Market cap of Zenlabs Ethica Ltd is 14 Cr

What are the key factors driving the stock performance of Oxygenta Pharmaceutical Ltd and Zenlabs Ethica Ltd?

The stock performance of Oxygenta Pharmaceutical Ltd and Zenlabs Ethica Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Oxygenta Pharmaceutical Ltd and Zenlabs Ethica Ltd?

As of May 3, 2026, the Oxygenta Pharmaceutical Ltd stock price is INR ₹54.34. On the other hand, Zenlabs Ethica Ltd stock price is INR ₹22.9.

How do dividend payouts of Oxygenta Pharmaceutical Ltd and Zenlabs Ethica Ltd compare?

To compare the dividend payouts of Oxygenta Pharmaceutical Ltd and Zenlabs Ethica Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.